Drug Type Small molecule drug |
Synonyms LN 6023, LN6023 |
Target |
Mechanism ACKR3 agonists(atypical chemokine receptor 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H32N6O2S |
InChIKeyJUYRBVWTTFJCFX-UHFFFAOYSA-N |
CAS Registry3035427-42-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Preclinical | DE | 23 Sep 2022 |